A related protein, AKR1B1, has been highlighted as a potential drug target following a proteomic analysis of patient vitreous samples, while genetic association studies find the AKR1B1 gene to be the most prominent risk gene in diabetic retinopathy [39,40]. The gene discussed is AKR1B1; the disease is diabetic retinopathy.